Study for Hospitalized Heart Failure Patients

What we are studying

The study drug is being evaluated as a possible treatment for congestive heart failure (CHF). Increased fluid and inability to remove fluid from the body are problems linked to CHF. Testing is being conducted to determine how useful the study drug will be in treating CHF.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Must be hospitalized for worsening heart failure

What is involved

  • Participants will be in the study for about one month and receive study drug for up to 7 days while in the hospital.

Compensation

None

Contact Information

Study Coordinator
Deborah Wesley
Email
dwesley@wakehealth.edu
Phone
336-716-2924

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.